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license (http://creativecommons.org/Abstract We present the case of a patient with non-ST-elevated myocardial infarction due to
very late stent thrombosis 2 years after a sirolimus-eluting stent implantation (SES). Optical
coherence tomography (OCT) imaging identified vessel wall destruction of the whole stented
coronary segment with multiple cavity formations along the entire stent length, severe strut
malapposition and thrombi. The patient was treated successfully with the implantation of a
bare metal stent (BMS). Follow-up OCT imaging at 12 months revealed the improvement of
vascular healing with complete re-endothelialization of the distal parts of the new BMS, while
the stent body remained partly uncovered, suggesting vascular toxicity due to the old SES.
Short abstract: The current case is the first to demonstrate the vascular response to a bare
metal stent (BMS) implantation inside an old sirolimus-eluting stent with very late stent
thrombosis in vivo using optical coherence tomography (OCT). Treatment of very late stent
thrombosis with a new BMS resulted in a favourable outcome with improved vascular h ealing
at 12 months, as identified by OCT.
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Clinical studies have shown that drug-eluting stents (DES)
inhibit neointimal proliferation and dramatically reduce in-
stent restenosis.1,2 However, DES may affect the normal
vascular healing process, resulting in delayed endothelial-
ization and increased susceptibility to late stent throm-
bosis, an infrequent but life threatening complication.3e5
Optical coherence tomography (OCT), which offers ultra-
high image resolution, offers a unique opportunity for
in vivo assessment of the vascular response to DES.6 We
present the case of a patient with non-ST-elevated
myocardial infarction due to very late stent thrombosis 2
years after a sirolimus-eluting stent (SES) implantation.
OCT identified vessel wall destruction of the stented cor-
onary segment, suggesting a severe localized hypersensi-
tivity reaction to SES. Follow-up OCT at 12 months after
successful treatment with a bare metal stent revealed
improved vascular healing.
Case report
A 44-year-old man without cardiovascular risk factors was
admitted to our hospital because of a non-ST elevatedFigure 1 Baseline angiographic and OCT findings. A. Peri-sten
between lines B and D). B, C and D. OCT images reveal: B. the pr
(arrows) C. and D. Severe strut malapposition (white arrows) and m
the stent struts are covered by a layer of tissue similar to neo-endmyocardial infarction. The patient had a history of percu-
taneous coronary intervention (PCI) with a sirolimus-eluting
stent (SES) that was 3.0 mm in diameter and 23 mm in
length (Cypher stent, Cordis, Johnson & Johnson, Miami,
Florida) and was implanted in the mid left anterior
descending artery 2 years prior. During his current admis-
sion, coronary angiography revealed non-significant coro-
nary artery stenosis. However, at the site of the old Cypher
stent, peri-stent contrast staining was observed (Fig. 1A).
OCT imaging found that along the entire stent length there
was severe strut malapposition and multiple cavity forma-
tions between stent struts with a depth range of 0.5 to
2.1 mm (Fig. 1C and 1D). Moreover, at the proximal part of
the stent, multiple red thrombi were observed (Fig. 1B)
that almost obstructed the lumen of the vessel. Interest-
ingly, most of the stent struts were totally covered by a
layer of tissue similar to neo-endothelium (Fig. 1C, 1D). We
decided to treat the patient with a new bare-metal stent
(BMS) that was 2.75 mm in diameter and 30 mm in length.
After stent implantation, we performed multiple di-
latations with a 3.0 mm balloon under high atmosphere,
with a good angiographic result (Fig. 2A). OCT imaging of
the new BMS showed good expansion and apposition of the
stent (Fig. 2B); however, some large cavities were still
present between the stent struts (Fig. 2C and 2D). Notably,t contrast staining in mid LAD (the coronary artery segment
oximal part of the old Cypher stent with multiple red thrombi
ultiple cavity formations (yellow arrows). Interestingly, most of
othelium.
Figure 2 Angiographic and OCT findings immediately after PCI in mid LAD. A. Good angiographic results after BMS implantation
(2,75 mm in diameter and 30 mm in length) in mid LAD. B, C and D. OCT images reveal: B. Well- expanded stent struts of the BMS
with good apposition (arrows). C. and D. Regression of the number and the size of the cavity formations (yellow arrows) and the
strut malapposition of the old Cypher stent (white arrows).
Management of very late stent thrombosis 131strut malapposition of the old Cypher stent became less
severe (Fig. 2C).
A follow-up angiography at 12 months demonstrated that
the good angiographic result was unchanged (Fig. 4A). OCTFigure 3 OCT findings at 12 months after the BMS implantation. T
and D correspond to the BMS edges) as well as the old Cypher sten
images reveal the distal (A) and the proximal (D) edges of the BMS
(double arrows), likely corresponding to neo-endothelium. B and C
the old Cypher stent which were covered by a tissue similar to neo-e
arrows) and Cypher (white arrows) are visible. Disappearance of
noticed at this part of the stented vessel.at 12 months showed that the distal and proximal edges of
the BMS, which were outside of the old Cypher stent, had
been totally covered by a thick layer of tissue (up to 650
mm), likely corresponding to neo-endothelium (Fig. 3A andhe longitudinal OCT image reveals the whole BMS stent (lines A
t (yellow stars correspond to the Cypher edges). A and D. OCT
outside of the old Cypher covered with a thick layer of tissue
. OCT images reveal the sites of the BMS covering the edges of
ndothelium (double arrows). The struts of both stents, BMS (red
the cavity formations and the stent strut malapposition was
Figure 4 Angiographic and OCT findings at 12 months after the BMS implantation. A. Angiographic image reveals that the good
PCI result remained unchanged. B, C and D. OCT images corresponding to the BMS body reveal several uncovered struts with mild
malapposition (white arrows). Some cavity formations were still present at this part of the stented vessel (yellow arrows).
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of the old Cypher was also covered by a tissue similar to neo-
endothelium (Fig. 3B and 3C). In contrast, most of the struts
of the BMS body, which were inside the old Cypher,
remained uncovered, suggesting vascular toxicity due to SES
at this vessel segment (Fig. 4B, 4C, 4D). Furthermore, a
significant regression of the size and the number of the
interstrut cavity formations were observed along the entire
length of the old Cypher stent (Figs. 3 and 4).Discussion
Late stent thrombosis remains an infrequent but life
threatening complication after DES implantation that is
primarily attributed to delayed arterial healing (i.e., lack
of re-endothelialization and poor strut coverage).3 Autopsy
studies3e5 have shown that the underlying mechanism of
late stent thrombosis for SES is localized strut hypersensi-
tivity. Recently, Kon et al.7 reported a case with peri-stent
contrast staining associated with very late stent thrombosis
after SES implantation. In that case, autopsy demonstrated
an aneurysm-like focal dilatation of the stented segment
with marked inflammatory cell infiltration. Additionally,
collapse and loss of the intimal tissue was found, which
caused stent malapposition. These pathological findingswere consistent with localized hypersensitivity vasculitis.7
Morino et al.8 also reported a case with peri-stent
contrast staining after SES implantation with multiple cav-
ity formations between stent struts due to vascular positive
remodelling, as detected by intravascular ultrasound. Sur-
prisingly, in that case, OCT demonstrated entirely covered
stent struts with no thrombus formation in these cavities.8
A very recent study suggested that this phenomenon of
multiple cavity formations after SES implantation seems to
be a specific morphological footprint of early generation
SES that is nearly absent in newer generation zotarolimus
and everolimus-eluting stents.9
To our knowledge, the current case is the first to show
the vascular response to a BMS implantation inside an old
Cypher stent with very late stent thrombosis in vivo using
OCT. OCT imaging of the Cypher stent thrombosis before
PCI revealed destruction of the stented vessel wall with
multiple cavity formations and severe strut malapposition.
Immediate post-PCI OCT demonstrated regression of both
strut malapposition and number and size of cavity forma-
tions. Follow-up OCT imaging at 12 months showed com-
plete re-endothelialization of the distal parts of the new
BMS covering the old Cypher, although the BMS body
remained partly uncovered. This type of vascular healing is
consistent with histopathological data reporting that
endothelial coverage is generally more complete at the
Management of very late stent thrombosis 133extreme proximal and distal regions of a stent versus the
middle segments.10,11 Furthermore, experimental models
have shown that re-endothelialization after BMS or DES
implantation occurs from proliferation and migration of
endothelial cells of the intact neighbouring coronary seg-
ments.10,11 We speculated that the implantation of a BMS
long enough to cover both entire length of the old Cypher
and the intact neighbouring coronary segments might offer
a stimuli for re-endothelialization of the whole stented
vascular segment.
The optimal treatment for stent thrombosis has not been
determined. Observational studies suggest that the primary
PCI for treatment of stent thrombosis is less effective and
long term clinical outcomes are unfavourable with high
mortality and recurrence rate.12e15 However, in our case,
the implantation of a BMS was a safe and effective treat-
ment for very late SES thrombosis with improved vascular
healing at 12 months. Still, randomized trials are urgently
needed to determine the optimal treatment strategy in
these patients.
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